HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

X-Linked Dominant Scapuloperoneal Myopathy

mutations in FHL1

Also Known As:

Scapuloperoneal Myopathy, X-Linked Dominant; Scapuloperoneal Myopathy, FHL1-Related

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
2.	Muscular Diseases (Myopathy)

Experts

1.	Barresi, R: 1 article (08/2016)
2.	Bushby, K: 1 article (08/2016)
3.	Hudson, J: 1 article (08/2016)
4.	Lochmüller, H: 1 article (08/2016)
5.	Polvikoski, T: 1 article (08/2016)
6.	Straub, V: 1 article (08/2016)
7.	Willis, T A: 1 article (08/2016)
8.	Wood, C L: 1 article (08/2016)
9.	Barral, Sandra: 1 article (01/2008)
10.	Blake, David M: 1 article (01/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to X-Linked Dominant Scapuloperoneal Myopathy:

1.

Proteins (Proteins, Gene)FDA Link

01/01/2008 - "X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1."
08/01/2016 - "Four and a half LIM protein 1 (FHL1/SLIM1) has recently been identified as the causative gene mutated in four distinct diseases affecting skeletal muscle that have overlapping features, including reducing body myopathy, X-linked myopathy, X-linked dominant scapuloperoneal myopathy and Emery-Dreifuss muscular dystrophy. "